Vinay Rajani of HDFC Securities says Divis Labs share price has broken out from the box pattern on the daily chart with the ...

Welcome to the Divis Labs Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.

Amid the rising volatility in the Indian equity markets, domestic brokerage firm BP Equities has shared its top picks for ...

Jefferies' top picks in the CRDMO space are Sai Lifesciences and Divi’s for strong execution and healthy growth outlook.

They have also shared their outlook on pharmaceuticals, telecom, healthcare, metals and banking, alongside broader commentary on India’s growth outlook, GDP trajectory and the evolving earnings cycle.

Citi said it believes Divi's Laboratories' revenue and earnings before interest, tax, depreciation, and amortisation (EBITDA) ...

Pharma stocks rose in Friday's trade after a White House release suggested the US President Donald Trump signed National Defense Authorization Act for the financial year 2026. It included the ...

Nifty Pharma index closed up 1.69% at 23126.85 today. The index has gained 1.00% over last one month. Among the constituents, Divis Laboratories Ltd added 4.38%, Ipca Laboratories Ltd rose 4.01% and ...

Divi's Laboratories Limited is an India-based company, which is engaged in pharmaceutical ingredients (APIs), intermediates and nutraceutical ingredients with predominance in exports. The Company’s ...

Net profit for the quarter jumped 35% to ₹689 crore, compared with ₹510 crore a year ago, aided by stronger volumes and improved cost efficiency.